SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-105601
Filing Date
2022-04-14
Accepted
2022-04-14 16:17:57
Documents
14
Period of Report
2022-04-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d363344d8k.htm   iXBRL 8-K 24650
2 EX-99.1 d363344dex991.htm EX-99.1 9816
6 GRAPHIC g363344g0414210654500.jpg GRAPHIC 3409
  Complete submission text file 0001193125-22-105601.txt   165005

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nexi-20220414.xsd EX-101.SCH 2834
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20220414_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20220414_pre.xml EX-101.PRE 11244
8 EXTRACTED XBRL INSTANCE DOCUMENT d363344d8k_htm.xml XML 3340
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 22827494
SIC: 2834 Pharmaceutical Preparations